Old Web
English
Sign In
Acemap
>
authorDetail
>
G.A.E. van t Klooster
G.A.E. van t Klooster
Protease
Virology
Medicine
Diabetes mellitus
Hepatitis C
2
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
855 ONCE-DAILY REGIMENS OF THE HCV NS3/4A-PROTEASE INHIBITOR TMC435350 ARE PREDICTED TO PROVIDE THERAPEUTIC EXPOSURE IN PLASMA AND LIVER
2008
Journal of Hepatology
G.A.E. van t Klooster
I. Vanwelkenhuysen
R. Hooijmaijers
K. Bol
Marieke Christiane Johanna Voets
J. Van Houdt
R. Verloes
Fatima Aharchi
K. Marien
P. Van Remoortere
F. Broeckaert
H. de Kock
K. Simmen
Show All
Source
Cite
Save
Citations (7)
64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY
2008
Journal of Hepatology
H. W. Reesink
R. Verloes
K. Abou Farha
A. C. M. Van Vliet
Christine J. Weegink
G.A.E. van t Klooster
Fatima Aharchi
K. Marien
P. Van Remoortere
H. de Kock
F. Broeckaert
Gregory Fanning
Paul Meyvisch
E. Van Beirendonck
K. Simmen
Show All
Source
Cite
Save
Citations (17)
1